Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 130 INDUSTRY 32 NIH 10 OTHER_GOV 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 25 Rectal Neoplasms 21 Colonic Neoplasms 11 Esophageal Neoplasms 6 Stomach Neoplasms 5 Neoplasm Metastasis 5 Adenocarcinoma Of Esophagus 5 Carcinoma, Non-Small-Cell Lung 2 Biliary Tract Neoplasms 2 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Metastatic Pancreatic Adenocarcinoma 1 Medulloblastoma 1 Lung Neoplasms 1 Hepatoblastoma 1 Gastrointestinal Neoplasms 1 Gastro Oesophageal Cancer 1 Fibrolamellar hepatocellular carcinoma 1 Familial ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Breast Neoplasms 1

Interventions

Gemcitabine 17 Fluorouracil 8 Capecitabine 6 Radiotherapy 5 Leucovorin 5 Albumin-Bound Paclitaxel 5 Taxes 4 Irinotecan 4 Cisplatin 4 130-nm albumin-bound paclitaxel 4 Specimen Handling 3 Radiotherapy, Conformal 3 Docetaxel 3 irinotecan sucrosofate 2 dehydroftorafur 2 Surgical Procedures, Operative 2 Radiosurgery 2 Pancreaticoduodenectomy 2 Chemotherapy, Adjuvant 2 Cetuximab 2 trametinib 1 tipifarnib 1 saracatinib 1 pegfilgrastim 1 lanreotide 1 ganitumab 1 durvalumab 1 conatumumab 1 beta-D-glucosylisophosphoramide mustard 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Pancreatic Neoplasms × Oxaliplatin × Clear all

NCT06094140 2026-05-06

NEO-IMPACT

Australasian Gastro-Intestinal Trials Group

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡